Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial
Abstract In this study, we investigated the effect of exenatide (EXE), a glucagon-like peptide (GLP)-1 receptor agonist, on kidney function, obesity indices, and glucose control in overweight/obese patients with type 2 diabetes mellitus (T2DM). A total of 159 overweight/obese patients with T2DM were...
Guardado en:
Autores principales: | Chao Kang, Qiao Qiao, Qiang Tong, Qian Bai, Chen Huang, Rong Fan, Hui Wang, Kanakaraju Kaliannan, Jian Wang, Jing Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff41a413345a4912b70a2f2d7da7fac4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
por: Megan Rodgers, et al.
Publicado: (2021) -
Overweight, obesity and meningioma risk: a meta-analysis.
por: Chuan Shao, et al.
Publicado: (2014) -
OUTCOME OF DIETARY INTERVENTION ON WEIGHT AND ANTHROPOMETRIC INDICES OF OVERWEIGHT AND OBESE FEMALES: A RANDOMIZED CONTROLLED TRIAL
por: Khola Noreen, et al.
Publicado: (2018) -
Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review
por: Cheng D, et al.
Publicado: (2021) -
Forecasting the Populations of Overweight and Obese Chinese Adults
por: Bai R, et al.
Publicado: (2020)